Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↡ to solve



    Fuel Your Discoveries




     Quick Explanation



    Yi Shen β€” scientific strength snapshot
    • Evidence-based breadth: Pubications span soft electronics/materials (), fungal systematics (), and host-pathogen/inflammation immunometabolism ().
    • Scientific rigor signal: Multiple works include mechanistic testing with appropriate controls and multi-modal measurements (e.g., DFT+materials characterization; multi-gene phylogenies; multi-modal immunology assays). Examples: and ).



     Long Explanation



    Author Review (Scientific Strength): Yi Shen
    What I’m reviewing: the provided publication list + the extracted paper-level evidence summaries/metadata you supplied.
    Epistemic note: you supplied limited author disambiguation/context (and one OpenAlex match appears to be for a different β€œYi/X. Y. Shen”). I therefore evaluate only what is explicitly present in your provided records.
    Quick evidence visualizations (from your extracted paper metadata)
    Each point/score below comes only from the paper_sci/novelty/general/usefulness/reproducibility numbers you provided for multiple works (not from external databases).
    1) Career-level citation metrics (as provided)
    • h-index: 3
    • Total citations: 16
    • Total papers: 8
    • Works list provided: 8 items (mostly chemistry/materials/crystal structures + one IR/HPLC discussion entry)
    Critical caution: h-index/citations and β€œYi Shen” can be severely affected by author name disambiguation. Your OpenAlex block appears to match other researchers with similar names; I therefore treat your supplied h-index/citation counts as only the β€œYi-Hong Shen” record you provided, and not as globally validated.
    2) What the supplied works suggest about scientific capability
    2A. Systems breadth, but with mechanistic anchors
    Across very different domains in your dataset (materials; fungal taxonomy; immunometabolism; developmental/endothelial biology; cell mechanobiology; host-parasite vector genetics; evolutionary genomics), there is a recurring pattern: mechanistic claims are paired with multi-modal measurements (e.g., DFT + SEM/XPS/FTIR in materials; multi-gene phylogenies + morphology + explicit barcode caveats in taxonomy; KO/KO + ROS assays + scRNA-seq + proteomics in immunometabolism).
    Evidence examples (directly tied to citations)
    • Materials / sustainable soft electronics: dynamic ionic-liquid + disulfide-crosslink driven microporosity and room-temperature self-healing with DFT support for bonding mechanism.
    • Mycology / integrative taxonomy: multi-gene phylogeny revised intrageneric structure + global ITS meta-analysis; the paper explicitly stresses ITS limitations for species delimitation and database labeling issues.
    • Immunometabolism / viral infection: suppression of Complex III assembly is presented as adaptive anti-inflammatory remodeling with both mechanistic (ROS/Qo-site) and systems-level (in vivo KO, scRNA-seq) evidence.
    • Evolutionary/phylogenetic method development: mechanistic enzyme architecture in PKS using genetics + biochemical reconstitution (AT-less PKS architecture) with explicit trans-acting AT concept and functional verification.
    3) Domain-agnostic strengths and likely scientific practices
    • Mechanism-first framing: Several papers’ extracted summaries emphasize that the authors go beyond β€œassociation” and test mechanistic steps (KO/overexpression; inhibition/functional disruption; barcode discordance caveats; enzyme domain-function in vitro reconstitution). Example mechanisms: .
    • Cross-validation across modalities: Many works appear to combine computational/analytical approaches with experimental readouts (DFT+materials; multi-locus phylogenetics+imaging; KO+scRNA-seq). When computational models are present, the extracted summaries often report parameters and inference workflows (e.g., MAFFT/IQ-TREE/MrBayes in taxonomy and DFT in materials) rather than only conceptual modeling.
    • Explicit limitations: Your extracted summaries repeatedly include limitation/bias discussions (sampling bias, discordant barcode behavior, small sample sizes, data deposition gaps). This is a positive rigor signal because it indicates awareness of failure modes rather than overclaiming universal generality. Example: ITS barcode limitations and database mislabeling are explicitly noted.
    4) Critical gaps / blind spots indicated by the supplied extracts
    • Reproducibility transparency varies: In your extracted summaries, some works state raw data are deposited (e.g., GEO accessions in the Kindlin-2/membrane mechanics example), while others state only supplementary material is available or even β€œavailable on request”. Where openness is weaker, external verification becomes harder. (For example, Complex III influenza work: .)
    • Domain generalization risk: Some findings appear model- or context-dependent: cell-line panels (KRAS/Aurora kinase A study in your dataset), ex vivo brain slice physiology, or single-pathogen/animal models. This increases false generalization risk and reduces confidence when extrapolating beyond the studied context. (Example context dependence: influenza + model-specific inflammatory remodeling. .)
    • Assay-dependent β€œmechanism”: In several extracted summaries, mechanistic readouts (e.g., CIN measurement, ROS-site assays, or barcode-like genetic proxies) can be assay-dependent. That doesn’t automatically invalidate results, but it lowers certainty about the exact causal node without orthogonal confirmation. (Example: the immunometabolism work relies on Complex III/Qo-site ROS reduction as a mechanistic driver; the causal link would need direct rescue experiments in more systems. .)
    5) Visual evidence: extracted β€œkey extracted data” where numbers were provided
    Below I plot only explicit numeric values that were included in your provided extracted data lists (no additional guessing).
    5A. Soft electronics elastomer: density reduction and mechanical/electrical healing (from https://dx.doi.org/10.1007/s40820-025-01942-7 extract)
    Extracted signals included: density reduction (70–80% porosity; density 20–30% of dense state), GF improvement (~3.0Γ— tension, ~2.75Γ— compression), and self-healing (~90% mechanical recovery in ~5h; ~98% electrical conductivity after 50 cut-reconnect cycles).
    6) Overall scientific assessment (skeptical, evidence-weighted)
    What appears strong
    • Method diversity with mechanistic depth: Your supplied extracts include biochemical reconstitution + genetics (PKS) , taxonomy with multi-gene inference and barcode performance caveats , and immunometabolic systems work with in vivo + in vitro + single-cell components .
    • Attention to failure modes: Many extracted summaries include specific limitations (sampling bias, reduced long-term aging data, assay-dependence, data-access gaps), which helps a reader gauge uncertainty rather than accepting claims uncritically.
    Where confidence should be lower
    • Author disambiguation uncertainty: The OpenAlex snippet you supplied likely refers to a different β€œYi Shen” than β€œYi-Hong Shen,” and the provided citation metrics (h-index=3) may not match the broader dataset of 2025–2026 biology/materials works you later supplied. This disconnect makes it harder to attribute scientific impact correctly.
    • Heterogeneity across studies: The extracts span multiple fields, which can be a strength (cross-disciplinary capability) but also a warning sign if the author’s contribution is uneven across domains or if co-authorship masks variability in leadership vs supporting roles (not assessable from your data).
    • Reproducibility/data accessibility not uniformly guaranteed: Where raw data accessions are missing or results are β€œavailable on request,” independent verification becomes slower and more uncertain (reducing the effective rigor score even if the experiments were careful).
    What would most disprove the strongest positive reading
    • Independent replication failures of key mechanistic claims (e.g., Complex III ROS β†’ monocyte recruitment causality; dynamic crosslink/self-healing mechanism in elastomers; ITS barcode delimitation failure modes) under the same assay conditions.
    • Clear evidence that some key findings are driven primarily by confounding factors or assay artifacts (e.g., KO pleiotropy in mitochondrial studies; barcode mislabeling dominating phylogenetic conclusions; batch effects in material synthesis).
    • Demonstrable mismatch between the cited author identity and the extracted works (name disambiguation), invalidating attribution.


    Feedback:   

    Updated: April 11, 2026

    BGPT Author Review



    Scientific Quality

    60%

    Based on the supplied abstracts/extracted evidence, Yi Shen shows credible mechanistic experimentation and cross-modal methods in several representative works (e.g., biochemical reconstitution/genetics; integrative phylogenetics; multi-modal immunometabolism). However, confidence is reduced by (i) author-name disambiguation risk between the provided β€œYi-Hong Shen” metrics and the broader set of 2025–2026 works, (ii) variable data accessibility/reproducibility transparency across extracts, and (iii) limited ability to assess individual leadership vs co-author contribution from the provided metadata. Net: moderately strong scientific competence but with attribution/reproducibility uncertainties.



    Communication Quality

    70%

    Communication appears structured and includes explicit limitation discussions in the supplied extracts. Still, the review content quality can’t be fully validated because we only have extracted summaries, not the full prose; also, cross-domain coverage is wide, which can dilute clarity of a single research narrative.



    Author Novelty

    70%

    Several provided works claim high novelty within their specific subfields (e.g., discrete trans-acting AT for an AT-less PKS architecture; integrative taxonomy with explicit barcode-performance evaluation; immunometabolic remodeling mechanism framing). The overall novelty rating is tempered by domain shifts and inability to assess whether the author consistently drives novel concepts vs contributes methodically.



    Scientific Rigor

    70%

    Rigor looks moderate-to-strong: mechanistic controls, multi-modal measurements, and explicit limitations are present in the extracts. Rigor is reduced when extracts suggest small sample sizes, reliance on model systems, assay-dependent mechanistic proxies, and missing public raw-data accessions.

     Top Data Sources ExportMCP



     Analysis Wizard



    No bioinformatics code is directly applicable to the provided author-review task; instead, it would summarize paper-level rigor metrics and visualize effect-size proxies from extracted tables.



     Hypothesis Graveyard



    The strongest reported phenotypes in the elastomer system could be primarily explained by reversible plasticization from CO2 rather than dynamic crosslinks; this would be unlikely if crosslink-disruption experiments abolish self-healing while keeping microporosity changes similar.


    The Complex III suppression anti-inflammatory phenotype might be an artifact of BR KO pleiotropic metabolic changes unrelated to Qo-site ROS; this would fall apart if targeted Qo-site ROS inhibition reproduces the same inflammatory program and rescue experiments restore inflammation by restoring the complex assembly pathway.

     Science Art


    Author Review: Yi Shen Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT